-
Alex Bodi utsedd till vicepresident för SCANDIC FINANCE-koncernen
-
تعيين أليكس بودي نائبًا لرئيس مجموعة SCANDIC FINANCE
-
SCANDIC FINANCEグループ、アレックス・ボディ氏を副社長に任命
-
SCANDIC FINANCE 그룹, 알렉스 보디 부사장 선임
-
亞歷克斯・博迪獲任命為 SCANDIC FINANCE 集團副總裁
-
Jersey Boys Anniversary Tour Opens in Birmingham With Gritty Account of Crime and Fame
-
Алекса Боді призначено віцепрезидентом групи SCANDIC FINANCE
-
Алекс Боди назначен вице-президентом группы SCANDIC FINANCE
-
Alex Bodi appointed Vice President of SCANDIC FINANCE GROUP
-
Alex Bodi, numit vicepreședinte al grupului SCANDIC FINANCE
-
Yealink Summit Addresses AI Governance and Workplace Trust
-
Essential Baking Tools for Christmas Cookie Perfection
-
Elon Musk jokes about moving businesses to space after US midterms
-
West Mercia Police opens 2027 cadet applications to Worcestershire teenagers
-
NHS to test blood screening designed to detect 13 cancers earlier
-
Worcestershire road closures announced for Remembrance Sunday events
-
Democrats near House takeover as voters judge Trump presidency
-
UBC professor describes police call after Galloway remark as act of care
-
Lethbridge submits interest in provincial ground ambulance contract
-
False voting claims spread rapidly during US Election Day
-
The Cat in the Hat expands its stakes to cosmic scale in animated reboot
-
Lettermen co-founder Tony Butala dies at 87
-
Byron Donalds wins Florida governor race and underscores Republican strength
-
James Talarico defeats Ken Paxton in historic Texas Senate result
-
Physicist Claims Alberta Data Center Releases Energy of 23 Atomic Bombs Daily
-
Commentator predicts possible US strike on Iran as regional tensions rise
-
Goa plans relationship-readiness course amid concern over divorces
-
Jordan Bardella's Wealth and Financial Transparency Under Scrutiny
-
Manchester United climbs standings after 3-2 Champions League win over Roma
-
India introduces four-layer motor insurance choice from December 15
-
Mutual fund returns show shifting leaders across market-cap categories
-
Polaris Renewable Energy Declares Quarterly Dividend
-
Armanino Foods to Attend Upcoming Investor Conferences
-
Loar Holdings Inc. Reports Q3 2026 Record Results and Upward Revision to 2026 Outlook and Full Year 2027 Outlook
-
Nine Mile Metals DDH WD-26-12 Intersects 2 High Grade VMS Zones Over 20m Including 3.33% Cu-Eq Over 12.0m, 4.40% Cu-Eq Over 7.0m With 8.35% Zn Over 7.0m with a Peak Intersect of 8.40% Cu-Eq
-
GameSquare's Hatchet Publishes Q3 2026 Live Streaming Trends Report
-
ReElement Announces $46 Million in Non-Dilutive Federal NMTC Allocation to Support Indiana Critical-Minerals Refining Expansion
-
Jerash Holdings (US), Inc. Declares Quarterly Dividend
-
NuRAN Targets Africa's Rural Connectivity Opportunity with More Than US$900 Million in Estimated Contract Revenue
-
ATWEC Technologies, Inc. (OTCID:ATWT) Reports August 2026 Revenue of $2.93 Million, Up 17.7% Year-over-Year
-
BioAdaptives to Acquire Xycota Biosciences to Pursue the Potential of At Home Psilocybin Treatment
-
Horizon Aircraft Signs MOU With Constance Lake First Nation to Bring Lifesaving Medical Aircraft to Remote and Isolated Indigenous Communities
-
Cosmos Health's CosmoFarm Begins Commissioning New Automated Order-Processing and Vehicle-Loading Infrastructure, Advancing Capacity That Could Support Over $120 Million in Annual Revenue
-
Abits Group Highlights Existing Datacenter Infrastructure and 24 MW Power Capacity to Support AI and HPC Hosting Expansion Strategy
-
Greene Concepts Highlights Be Water's Role in Health and Wellness
-
Impauer Technologies Announces Official Release of PauerOne V2 Featuring Integrated PauerEarn Rewards Engine
-
Clarity Tax Relief Publishes Analysis of the 2025 IRS Data Book Collection Figures
-
BlueFuture Aquatics, Inc. (Formerly NaturalShrimp) Announces Support for the Administration's America First Seafood Strategy
-
Strategic Metals Ltd. Announces Acquisition of Control and Direction of Additional Securities of GGL Resources Corp.
-
Glo Tanning Opens in Tempe With Red Light Therapy, Skincare and More
US authorities relax regulations on prescription opioids
US health officials issued new recommendations Thursday to relax restrictions for doctors prescribing opioids for pain, despite the risk of addiction.
The Centers for Disease Control (CDC) revised principles issued in 2016 in an attempt to curb the opioid overdose epidemic in the United States.
Unlike the previous document, the new guide refrains from setting thresholds in terms of dosage or prescription duration.
These had led doctors to suddenly cut or drastically reduce patients' doses. States and insurance companies were also inspired to set their own limits.
Chronic pain patients had complained that they no longer had access to the drugs that would allow them to lead a normal life, and had warned of the increased risk of suicide in their ranks.
The new recommendations, compiled in a 200-page report, seek a balance. One in five Americans suffers from chronic pain and "opioids can be essential medications for the management of pain, however, they carry considerable potential risk," the authors of the document wrote.
The guidelines are not "a replacement for clinical judgment or individualized, person-centered care" or "intended to be applied as inflexible standards of care," the report says.
But it recommends caution, warning that opioids should be considered only after other pain treatments have failed, and at each step, physicians should discuss the issue with their patients.
If they decide to use opioids, they should first prescribe the lowest effective dose and then closely monitor the effects of the treatment.
If problems arise, physicians should also avoid abruptly terminating opioid prescriptions and should ensure appropriate care for those with complications.
As a precautionary measure, the agency recommends that people using opioids over a prolonged period be offered Naloxone, an antidote that can save someone who is overdosing, said Christopher Jones, a senior CDC official, at a press briefing.
Opioid prescriptions increased fourfold between 1999 and 2010 in the United States. Although the trend has reversed since 2016, they have created addictions and driven some patients to drugs like heroin and fentanyl.
Last year, the US had a record 107,000 overdose deaths, more than 70 percent of which were from illegal synthetic opioids.
R.Garcia--AT